Global Microbiome CDMO Market Growth (Status and Outlook) 2026-2032
The global Microbiome CDMO market size is predicted to grow from US$ 1658 million in 2025 to US$ 3225 million in 2032; it is expected to grow at a CAGR of 10.2% from 2026 to 2032.
Microbiome CDMO (Contract Development and Manufacturing Organization) is an organization that specializes in providing customized manufacturing and development services to biotechnology and pharmaceutical companies. They mainly focus on providing microbiome research with the entire process from samples to commercial products, including microbiome isolation, culture, identification, storage, extraction, preparation and related product development.
With the continuous deepening of microbiome research, more and more companies and research institutions have begun to realize the application potential of microbiome in medicine, agriculture, food and other fields, which has brought huge market demand to the microbiome CDMO industry.
LPI (LP Information)' newest research report, the ?Microbiome CDMO Industry Forecast? looks at past sales and reviews total world Microbiome CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Microbiome CDMO sales for 2026 through 2032. With Microbiome CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbiome CDMO industry.
This Insight Report provides a comprehensive analysis of the global Microbiome CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microbiome CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Microbiome CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbiome CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbiome CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Microbiome CDMO (Contract Development and Manufacturing Organization) is an organization that specializes in providing customized manufacturing and development services to biotechnology and pharmaceutical companies. They mainly focus on providing microbiome research with the entire process from samples to commercial products, including microbiome isolation, culture, identification, storage, extraction, preparation and related product development.
With the continuous deepening of microbiome research, more and more companies and research institutions have begun to realize the application potential of microbiome in medicine, agriculture, food and other fields, which has brought huge market demand to the microbiome CDMO industry.
LPI (LP Information)' newest research report, the ?Microbiome CDMO Industry Forecast? looks at past sales and reviews total world Microbiome CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Microbiome CDMO sales for 2026 through 2032. With Microbiome CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbiome CDMO industry.
This Insight Report provides a comprehensive analysis of the global Microbiome CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microbiome CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Microbiome CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbiome CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbiome CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Microbial CDMO
- Antibiotic CDMO
- Phage CDMO
- Bacteriocins CDMO
- Vaccine R&D
- Biopharmaceutical
- Cell Therapy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Arranta Bio
- Wacker Chemie AG
- Bactera
- SGS Quay Pharma
- Biose
- EnteroBiotix
- Genome And Company
- Lallemand Health Solutions
- List Bio
- Rise BioServices
- Lonza
- MaaT Pharma
- NIZO
- Quay Pharmaceuticals
- Recipharm
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microbiome CDMO Market Size (2021-2032)
2.1.2 Microbiome CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Microbiome CDMO by Country/Region (2021, 2025 & 2032)
2.2 Microbiome CDMO Segment by Type
2.2.1 Microbial CDMO
2.2.2 Antibiotic CDMO
2.2.3 Phage CDMO
2.2.4 Bacteriocins CDMO
2.2.5 Microbiome CDMO Market Size by Type
2.2.5.1 Microbiome CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Microbiome CDMO Market Size Market Share by Type (2021-2026)
2.3 Microbiome CDMO Segment by Application
2.3.1 Vaccine R&D
2.3.2 Biopharmaceutical
2.3.3 Cell Therapy
2.3.4 Others
2.3.5 Microbiome CDMO Market Size by Application
2.3.5.1 Microbiome CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Microbiome CDMO Market Size Market Share by Application (2021-2026)
3 MICROBIOME CDMO MARKET SIZE BY PLAYER
3.1 Microbiome CDMO Market Size Market Share by Player
3.1.1 Global Microbiome CDMO Revenue by Player (2021-2026)
3.1.2 Global Microbiome CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Microbiome CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MICROBIOME CDMO BY REGION
4.1 Microbiome CDMO Market Size by Region (2021-2026)
4.2 Global Microbiome CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Microbiome CDMO Market Size Growth (2021-2026)
4.4 APAC Microbiome CDMO Market Size Growth (2021-2026)
4.5 Europe Microbiome CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Microbiome CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Microbiome CDMO Market Size by Country (2021-2026)
5.2 Americas Microbiome CDMO Market Size by Type (2021-2026)
5.3 Americas Microbiome CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microbiome CDMO Market Size by Region (2021-2026)
6.2 APAC Microbiome CDMO Market Size by Type (2021-2026)
6.3 APAC Microbiome CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Microbiome CDMO Market Size by Country (2021-2026)
7.2 Europe Microbiome CDMO Market Size by Type (2021-2026)
7.3 Europe Microbiome CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microbiome CDMO by Region (2021-2026)
8.2 Middle East & Africa Microbiome CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Microbiome CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MICROBIOME CDMO MARKET FORECAST
10.1 Global Microbiome CDMO Forecast by Region (2027-2032)
10.1.1 Global Microbiome CDMO Forecast by Region (2027-2032)
10.1.2 Americas Microbiome CDMO Forecast
10.1.3 APAC Microbiome CDMO Forecast
10.1.4 Europe Microbiome CDMO Forecast
10.1.5 Middle East & Africa Microbiome CDMO Forecast
10.2 Americas Microbiome CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Microbiome CDMO Forecast
10.2.2 Canada Market Microbiome CDMO Forecast
10.2.3 Mexico Market Microbiome CDMO Forecast
10.2.4 Brazil Market Microbiome CDMO Forecast
10.3 APAC Microbiome CDMO Forecast by Region (2027-2032)
10.3.1 China Microbiome CDMO Market Forecast
10.3.2 Japan Market Microbiome CDMO Forecast
10.3.3 Korea Market Microbiome CDMO Forecast
10.3.4 Southeast Asia Market Microbiome CDMO Forecast
10.3.5 India Market Microbiome CDMO Forecast
10.3.6 Australia Market Microbiome CDMO Forecast
10.4 Europe Microbiome CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Microbiome CDMO Forecast
10.4.2 France Market Microbiome CDMO Forecast
10.4.3 UK Market Microbiome CDMO Forecast
10.4.4 Italy Market Microbiome CDMO Forecast
10.4.5 Russia Market Microbiome CDMO Forecast
10.5 Middle East & Africa Microbiome CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Microbiome CDMO Forecast
10.5.2 South Africa Market Microbiome CDMO Forecast
10.5.3 Israel Market Microbiome CDMO Forecast
10.5.4 Turkey Market Microbiome CDMO Forecast
10.6 Global Microbiome CDMO Forecast by Type (2027-2032)
10.7 Global Microbiome CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Microbiome CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Arranta Bio
11.1.1 Arranta Bio Company Information
11.1.2 Arranta Bio Microbiome CDMO Product Offered
11.1.3 Arranta Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Arranta Bio Main Business Overview
11.1.5 Arranta Bio Latest Developments
11.2 Wacker Chemie AG
11.2.1 Wacker Chemie AG Company Information
11.2.2 Wacker Chemie AG Microbiome CDMO Product Offered
11.2.3 Wacker Chemie AG Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Wacker Chemie AG Main Business Overview
11.2.5 Wacker Chemie AG Latest Developments
11.3 Bactera
11.3.1 Bactera Company Information
11.3.2 Bactera Microbiome CDMO Product Offered
11.3.3 Bactera Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bactera Main Business Overview
11.3.5 Bactera Latest Developments
11.4 SGS Quay Pharma
11.4.1 SGS Quay Pharma Company Information
11.4.2 SGS Quay Pharma Microbiome CDMO Product Offered
11.4.3 SGS Quay Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 SGS Quay Pharma Main Business Overview
11.4.5 SGS Quay Pharma Latest Developments
11.5 Biose
11.5.1 Biose Company Information
11.5.2 Biose Microbiome CDMO Product Offered
11.5.3 Biose Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Biose Main Business Overview
11.5.5 Biose Latest Developments
11.6 EnteroBiotix
11.6.1 EnteroBiotix Company Information
11.6.2 EnteroBiotix Microbiome CDMO Product Offered
11.6.3 EnteroBiotix Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 EnteroBiotix Main Business Overview
11.6.5 EnteroBiotix Latest Developments
11.7 Genome And Company
11.7.1 Genome And Company Company Information
11.7.2 Genome And Company Microbiome CDMO Product Offered
11.7.3 Genome And Company Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Genome And Company Main Business Overview
11.7.5 Genome And Company Latest Developments
11.8 Lallemand Health Solutions
11.8.1 Lallemand Health Solutions Company Information
11.8.2 Lallemand Health Solutions Microbiome CDMO Product Offered
11.8.3 Lallemand Health Solutions Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Lallemand Health Solutions Main Business Overview
11.8.5 Lallemand Health Solutions Latest Developments
11.9 List Bio
11.9.1 List Bio Company Information
11.9.2 List Bio Microbiome CDMO Product Offered
11.9.3 List Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 List Bio Main Business Overview
11.9.5 List Bio Latest Developments
11.10 Rise BioServices
11.10.1 Rise BioServices Company Information
11.10.2 Rise BioServices Microbiome CDMO Product Offered
11.10.3 Rise BioServices Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Rise BioServices Main Business Overview
11.10.5 Rise BioServices Latest Developments
11.11 Lonza
11.11.1 Lonza Company Information
11.11.2 Lonza Microbiome CDMO Product Offered
11.11.3 Lonza Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lonza Main Business Overview
11.11.5 Lonza Latest Developments
11.12 MaaT Pharma
11.12.1 MaaT Pharma Company Information
11.12.2 MaaT Pharma Microbiome CDMO Product Offered
11.12.3 MaaT Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 MaaT Pharma Main Business Overview
11.12.5 MaaT Pharma Latest Developments
11.13 NIZO
11.13.1 NIZO Company Information
11.13.2 NIZO Microbiome CDMO Product Offered
11.13.3 NIZO Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 NIZO Main Business Overview
11.13.5 NIZO Latest Developments
11.14 Quay Pharmaceuticals
11.14.1 Quay Pharmaceuticals Company Information
11.14.2 Quay Pharmaceuticals Microbiome CDMO Product Offered
11.14.3 Quay Pharmaceuticals Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Quay Pharmaceuticals Main Business Overview
11.14.5 Quay Pharmaceuticals Latest Developments
11.15 Recipharm
11.15.1 Recipharm Company Information
11.15.2 Recipharm Microbiome CDMO Product Offered
11.15.3 Recipharm Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Recipharm Main Business Overview
11.15.5 Recipharm Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microbiome CDMO Market Size (2021-2032)
2.1.2 Microbiome CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Microbiome CDMO by Country/Region (2021, 2025 & 2032)
2.2 Microbiome CDMO Segment by Type
2.2.1 Microbial CDMO
2.2.2 Antibiotic CDMO
2.2.3 Phage CDMO
2.2.4 Bacteriocins CDMO
2.2.5 Microbiome CDMO Market Size by Type
2.2.5.1 Microbiome CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Microbiome CDMO Market Size Market Share by Type (2021-2026)
2.3 Microbiome CDMO Segment by Application
2.3.1 Vaccine R&D
2.3.2 Biopharmaceutical
2.3.3 Cell Therapy
2.3.4 Others
2.3.5 Microbiome CDMO Market Size by Application
2.3.5.1 Microbiome CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Microbiome CDMO Market Size Market Share by Application (2021-2026)
3 MICROBIOME CDMO MARKET SIZE BY PLAYER
3.1 Microbiome CDMO Market Size Market Share by Player
3.1.1 Global Microbiome CDMO Revenue by Player (2021-2026)
3.1.2 Global Microbiome CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Microbiome CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MICROBIOME CDMO BY REGION
4.1 Microbiome CDMO Market Size by Region (2021-2026)
4.2 Global Microbiome CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Microbiome CDMO Market Size Growth (2021-2026)
4.4 APAC Microbiome CDMO Market Size Growth (2021-2026)
4.5 Europe Microbiome CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Microbiome CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Microbiome CDMO Market Size by Country (2021-2026)
5.2 Americas Microbiome CDMO Market Size by Type (2021-2026)
5.3 Americas Microbiome CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microbiome CDMO Market Size by Region (2021-2026)
6.2 APAC Microbiome CDMO Market Size by Type (2021-2026)
6.3 APAC Microbiome CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Microbiome CDMO Market Size by Country (2021-2026)
7.2 Europe Microbiome CDMO Market Size by Type (2021-2026)
7.3 Europe Microbiome CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microbiome CDMO by Region (2021-2026)
8.2 Middle East & Africa Microbiome CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Microbiome CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MICROBIOME CDMO MARKET FORECAST
10.1 Global Microbiome CDMO Forecast by Region (2027-2032)
10.1.1 Global Microbiome CDMO Forecast by Region (2027-2032)
10.1.2 Americas Microbiome CDMO Forecast
10.1.3 APAC Microbiome CDMO Forecast
10.1.4 Europe Microbiome CDMO Forecast
10.1.5 Middle East & Africa Microbiome CDMO Forecast
10.2 Americas Microbiome CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Microbiome CDMO Forecast
10.2.2 Canada Market Microbiome CDMO Forecast
10.2.3 Mexico Market Microbiome CDMO Forecast
10.2.4 Brazil Market Microbiome CDMO Forecast
10.3 APAC Microbiome CDMO Forecast by Region (2027-2032)
10.3.1 China Microbiome CDMO Market Forecast
10.3.2 Japan Market Microbiome CDMO Forecast
10.3.3 Korea Market Microbiome CDMO Forecast
10.3.4 Southeast Asia Market Microbiome CDMO Forecast
10.3.5 India Market Microbiome CDMO Forecast
10.3.6 Australia Market Microbiome CDMO Forecast
10.4 Europe Microbiome CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Microbiome CDMO Forecast
10.4.2 France Market Microbiome CDMO Forecast
10.4.3 UK Market Microbiome CDMO Forecast
10.4.4 Italy Market Microbiome CDMO Forecast
10.4.5 Russia Market Microbiome CDMO Forecast
10.5 Middle East & Africa Microbiome CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Microbiome CDMO Forecast
10.5.2 South Africa Market Microbiome CDMO Forecast
10.5.3 Israel Market Microbiome CDMO Forecast
10.5.4 Turkey Market Microbiome CDMO Forecast
10.6 Global Microbiome CDMO Forecast by Type (2027-2032)
10.7 Global Microbiome CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Microbiome CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Arranta Bio
11.1.1 Arranta Bio Company Information
11.1.2 Arranta Bio Microbiome CDMO Product Offered
11.1.3 Arranta Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Arranta Bio Main Business Overview
11.1.5 Arranta Bio Latest Developments
11.2 Wacker Chemie AG
11.2.1 Wacker Chemie AG Company Information
11.2.2 Wacker Chemie AG Microbiome CDMO Product Offered
11.2.3 Wacker Chemie AG Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Wacker Chemie AG Main Business Overview
11.2.5 Wacker Chemie AG Latest Developments
11.3 Bactera
11.3.1 Bactera Company Information
11.3.2 Bactera Microbiome CDMO Product Offered
11.3.3 Bactera Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bactera Main Business Overview
11.3.5 Bactera Latest Developments
11.4 SGS Quay Pharma
11.4.1 SGS Quay Pharma Company Information
11.4.2 SGS Quay Pharma Microbiome CDMO Product Offered
11.4.3 SGS Quay Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 SGS Quay Pharma Main Business Overview
11.4.5 SGS Quay Pharma Latest Developments
11.5 Biose
11.5.1 Biose Company Information
11.5.2 Biose Microbiome CDMO Product Offered
11.5.3 Biose Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Biose Main Business Overview
11.5.5 Biose Latest Developments
11.6 EnteroBiotix
11.6.1 EnteroBiotix Company Information
11.6.2 EnteroBiotix Microbiome CDMO Product Offered
11.6.3 EnteroBiotix Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 EnteroBiotix Main Business Overview
11.6.5 EnteroBiotix Latest Developments
11.7 Genome And Company
11.7.1 Genome And Company Company Information
11.7.2 Genome And Company Microbiome CDMO Product Offered
11.7.3 Genome And Company Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Genome And Company Main Business Overview
11.7.5 Genome And Company Latest Developments
11.8 Lallemand Health Solutions
11.8.1 Lallemand Health Solutions Company Information
11.8.2 Lallemand Health Solutions Microbiome CDMO Product Offered
11.8.3 Lallemand Health Solutions Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Lallemand Health Solutions Main Business Overview
11.8.5 Lallemand Health Solutions Latest Developments
11.9 List Bio
11.9.1 List Bio Company Information
11.9.2 List Bio Microbiome CDMO Product Offered
11.9.3 List Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 List Bio Main Business Overview
11.9.5 List Bio Latest Developments
11.10 Rise BioServices
11.10.1 Rise BioServices Company Information
11.10.2 Rise BioServices Microbiome CDMO Product Offered
11.10.3 Rise BioServices Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Rise BioServices Main Business Overview
11.10.5 Rise BioServices Latest Developments
11.11 Lonza
11.11.1 Lonza Company Information
11.11.2 Lonza Microbiome CDMO Product Offered
11.11.3 Lonza Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lonza Main Business Overview
11.11.5 Lonza Latest Developments
11.12 MaaT Pharma
11.12.1 MaaT Pharma Company Information
11.12.2 MaaT Pharma Microbiome CDMO Product Offered
11.12.3 MaaT Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 MaaT Pharma Main Business Overview
11.12.5 MaaT Pharma Latest Developments
11.13 NIZO
11.13.1 NIZO Company Information
11.13.2 NIZO Microbiome CDMO Product Offered
11.13.3 NIZO Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 NIZO Main Business Overview
11.13.5 NIZO Latest Developments
11.14 Quay Pharmaceuticals
11.14.1 Quay Pharmaceuticals Company Information
11.14.2 Quay Pharmaceuticals Microbiome CDMO Product Offered
11.14.3 Quay Pharmaceuticals Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Quay Pharmaceuticals Main Business Overview
11.14.5 Quay Pharmaceuticals Latest Developments
11.15 Recipharm
11.15.1 Recipharm Company Information
11.15.2 Recipharm Microbiome CDMO Product Offered
11.15.3 Recipharm Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Recipharm Main Business Overview
11.15.5 Recipharm Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Microbiome CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Microbiome CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Microbial CDMO
Table 4. Major Players of Antibiotic CDMO
Table 5. Major Players of Phage CDMO
Table 6. Major Players of Bacteriocins CDMO
Table 7. Microbiome CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Microbiome CDMO Market Size Market Share by Type (2021-2026)
Table 10. Microbiome CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Microbiome CDMO Market Size Market Share by Application (2021-2026)
Table 13. Global Microbiome CDMO Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Microbiome CDMO Revenue Market Share by Player (2021-2026)
Table 15. Microbiome CDMO Key Players Head office and Products Offered
Table 16. Microbiome CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Microbiome CDMO Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Microbiome CDMO Market Size Market Share by Region (2021-2026)
Table 21. Global Microbiome CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Microbiome CDMO Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Microbiome CDMO Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Microbiome CDMO Market Size Market Share by Country (2021-2026)
Table 25. Americas Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Microbiome CDMO Market Size Market Share by Type (2021-2026)
Table 27. Americas Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Microbiome CDMO Market Size Market Share by Application (2021-2026)
Table 29. APAC Microbiome CDMO Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Microbiome CDMO Market Size Market Share by Region (2021-2026)
Table 31. APAC Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Microbiome CDMO Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Microbiome CDMO Market Size Market Share by Country (2021-2026)
Table 35. Europe Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Microbiome CDMO Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Microbiome CDMO
Table 41. Key Market Challenges & Risks of Microbiome CDMO
Table 42. Key Industry Trends of Microbiome CDMO
Table 43. Global Microbiome CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Microbiome CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Microbiome CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Microbiome CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Arranta Bio Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 48. Arranta Bio Microbiome CDMO Product Offered
Table 49. Arranta Bio Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Arranta Bio Main Business
Table 51. Arranta Bio Latest Developments
Table 52. Wacker Chemie AG Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 53. Wacker Chemie AG Microbiome CDMO Product Offered
Table 54. Wacker Chemie AG Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Wacker Chemie AG Main Business
Table 56. Wacker Chemie AG Latest Developments
Table 57. Bactera Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 58. Bactera Microbiome CDMO Product Offered
Table 59. Bactera Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bactera Main Business
Table 61. Bactera Latest Developments
Table 62. SGS Quay Pharma Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 63. SGS Quay Pharma Microbiome CDMO Product Offered
Table 64. SGS Quay Pharma Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. SGS Quay Pharma Main Business
Table 66. SGS Quay Pharma Latest Developments
Table 67. Biose Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 68. Biose Microbiome CDMO Product Offered
Table 69. Biose Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Biose Main Business
Table 71. Biose Latest Developments
Table 72. EnteroBiotix Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 73. EnteroBiotix Microbiome CDMO Product Offered
Table 74. EnteroBiotix Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. EnteroBiotix Main Business
Table 76. EnteroBiotix Latest Developments
Table 77. Genome And Company Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 78. Genome And Company Microbiome CDMO Product Offered
Table 79. Genome And Company Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Genome And Company Main Business
Table 81. Genome And Company Latest Developments
Table 82. Lallemand Health Solutions Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 83. Lallemand Health Solutions Microbiome CDMO Product Offered
Table 84. Lallemand Health Solutions Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Lallemand Health Solutions Main Business
Table 86. Lallemand Health Solutions Latest Developments
Table 87. List Bio Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 88. List Bio Microbiome CDMO Product Offered
Table 89. List Bio Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. List Bio Main Business
Table 91. List Bio Latest Developments
Table 92. Rise BioServices Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 93. Rise BioServices Microbiome CDMO Product Offered
Table 94. Rise BioServices Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Rise BioServices Main Business
Table 96. Rise BioServices Latest Developments
Table 97. Lonza Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 98. Lonza Microbiome CDMO Product Offered
Table 99. Lonza Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Lonza Main Business
Table 101. Lonza Latest Developments
Table 102. MaaT Pharma Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 103. MaaT Pharma Microbiome CDMO Product Offered
Table 104. MaaT Pharma Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. MaaT Pharma Main Business
Table 106. MaaT Pharma Latest Developments
Table 107. NIZO Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 108. NIZO Microbiome CDMO Product Offered
Table 109. NIZO Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. NIZO Main Business
Table 111. NIZO Latest Developments
Table 112. Quay Pharmaceuticals Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 113. Quay Pharmaceuticals Microbiome CDMO Product Offered
Table 114. Quay Pharmaceuticals Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Quay Pharmaceuticals Main Business
Table 116. Quay Pharmaceuticals Latest Developments
Table 117. Recipharm Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 118. Recipharm Microbiome CDMO Product Offered
Table 119. Recipharm Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Recipharm Main Business
Table 121. Recipharm Latest Developments
Table 1. Microbiome CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Microbiome CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Microbial CDMO
Table 4. Major Players of Antibiotic CDMO
Table 5. Major Players of Phage CDMO
Table 6. Major Players of Bacteriocins CDMO
Table 7. Microbiome CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Microbiome CDMO Market Size Market Share by Type (2021-2026)
Table 10. Microbiome CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Microbiome CDMO Market Size Market Share by Application (2021-2026)
Table 13. Global Microbiome CDMO Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Microbiome CDMO Revenue Market Share by Player (2021-2026)
Table 15. Microbiome CDMO Key Players Head office and Products Offered
Table 16. Microbiome CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Microbiome CDMO Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Microbiome CDMO Market Size Market Share by Region (2021-2026)
Table 21. Global Microbiome CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Microbiome CDMO Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Microbiome CDMO Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Microbiome CDMO Market Size Market Share by Country (2021-2026)
Table 25. Americas Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Microbiome CDMO Market Size Market Share by Type (2021-2026)
Table 27. Americas Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Microbiome CDMO Market Size Market Share by Application (2021-2026)
Table 29. APAC Microbiome CDMO Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Microbiome CDMO Market Size Market Share by Region (2021-2026)
Table 31. APAC Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Microbiome CDMO Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Microbiome CDMO Market Size Market Share by Country (2021-2026)
Table 35. Europe Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Microbiome CDMO Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Microbiome CDMO Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Microbiome CDMO Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Microbiome CDMO
Table 41. Key Market Challenges & Risks of Microbiome CDMO
Table 42. Key Industry Trends of Microbiome CDMO
Table 43. Global Microbiome CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Microbiome CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Microbiome CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Microbiome CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Arranta Bio Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 48. Arranta Bio Microbiome CDMO Product Offered
Table 49. Arranta Bio Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Arranta Bio Main Business
Table 51. Arranta Bio Latest Developments
Table 52. Wacker Chemie AG Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 53. Wacker Chemie AG Microbiome CDMO Product Offered
Table 54. Wacker Chemie AG Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Wacker Chemie AG Main Business
Table 56. Wacker Chemie AG Latest Developments
Table 57. Bactera Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 58. Bactera Microbiome CDMO Product Offered
Table 59. Bactera Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bactera Main Business
Table 61. Bactera Latest Developments
Table 62. SGS Quay Pharma Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 63. SGS Quay Pharma Microbiome CDMO Product Offered
Table 64. SGS Quay Pharma Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. SGS Quay Pharma Main Business
Table 66. SGS Quay Pharma Latest Developments
Table 67. Biose Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 68. Biose Microbiome CDMO Product Offered
Table 69. Biose Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Biose Main Business
Table 71. Biose Latest Developments
Table 72. EnteroBiotix Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 73. EnteroBiotix Microbiome CDMO Product Offered
Table 74. EnteroBiotix Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. EnteroBiotix Main Business
Table 76. EnteroBiotix Latest Developments
Table 77. Genome And Company Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 78. Genome And Company Microbiome CDMO Product Offered
Table 79. Genome And Company Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Genome And Company Main Business
Table 81. Genome And Company Latest Developments
Table 82. Lallemand Health Solutions Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 83. Lallemand Health Solutions Microbiome CDMO Product Offered
Table 84. Lallemand Health Solutions Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Lallemand Health Solutions Main Business
Table 86. Lallemand Health Solutions Latest Developments
Table 87. List Bio Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 88. List Bio Microbiome CDMO Product Offered
Table 89. List Bio Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. List Bio Main Business
Table 91. List Bio Latest Developments
Table 92. Rise BioServices Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 93. Rise BioServices Microbiome CDMO Product Offered
Table 94. Rise BioServices Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Rise BioServices Main Business
Table 96. Rise BioServices Latest Developments
Table 97. Lonza Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 98. Lonza Microbiome CDMO Product Offered
Table 99. Lonza Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Lonza Main Business
Table 101. Lonza Latest Developments
Table 102. MaaT Pharma Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 103. MaaT Pharma Microbiome CDMO Product Offered
Table 104. MaaT Pharma Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. MaaT Pharma Main Business
Table 106. MaaT Pharma Latest Developments
Table 107. NIZO Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 108. NIZO Microbiome CDMO Product Offered
Table 109. NIZO Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. NIZO Main Business
Table 111. NIZO Latest Developments
Table 112. Quay Pharmaceuticals Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 113. Quay Pharmaceuticals Microbiome CDMO Product Offered
Table 114. Quay Pharmaceuticals Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Quay Pharmaceuticals Main Business
Table 116. Quay Pharmaceuticals Latest Developments
Table 117. Recipharm Details, Company Type, Microbiome CDMO Area Served and Its Competitors
Table 118. Recipharm Microbiome CDMO Product Offered
Table 119. Recipharm Microbiome CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Recipharm Main Business
Table 121. Recipharm Latest Developments
LIST OF FIGURES
Figure 1. Microbiome CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microbiome CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Microbiome CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Microbiome CDMO Sales Market Share by Country/Region (2025)
Figure 8. Microbiome CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Microbiome CDMO Market Size Market Share by Type in 2025
Figure 10. Microbiome CDMO in Vaccine R&D
Figure 11. Global Microbiome CDMO Market: Vaccine R&D (2021-2026) & ($ millions)
Figure 12. Microbiome CDMO in Biopharmaceutical
Figure 13. Global Microbiome CDMO Market: Biopharmaceutical (2021-2026) & ($ millions)
Figure 14. Microbiome CDMO in Cell Therapy
Figure 15. Global Microbiome CDMO Market: Cell Therapy (2021-2026) & ($ millions)
Figure 16. Microbiome CDMO in Others
Figure 17. Global Microbiome CDMO Market: Others (2021-2026) & ($ millions)
Figure 18. Global Microbiome CDMO Market Size Market Share by Application in 2025
Figure 19. Global Microbiome CDMO Revenue Market Share by Player in 2025
Figure 20. Global Microbiome CDMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Microbiome CDMO Value Market Share by Country in 2025
Figure 26. United States Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Microbiome CDMO Market Size Market Share by Region in 2025
Figure 31. APAC Microbiome CDMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Microbiome CDMO Market Size Market Share by Application (2021-2026)
Figure 33. China Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Microbiome CDMO Market Size Market Share by Country in 2025
Figure 40. Europe Microbiome CDMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Microbiome CDMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Microbiome CDMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Microbiome CDMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Microbiome CDMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 59. United States Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 63. China Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 67. India Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 70. France Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 71. UK Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 78. Global Microbiome CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Microbiome CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 1. Microbiome CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microbiome CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Microbiome CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Microbiome CDMO Sales Market Share by Country/Region (2025)
Figure 8. Microbiome CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Microbiome CDMO Market Size Market Share by Type in 2025
Figure 10. Microbiome CDMO in Vaccine R&D
Figure 11. Global Microbiome CDMO Market: Vaccine R&D (2021-2026) & ($ millions)
Figure 12. Microbiome CDMO in Biopharmaceutical
Figure 13. Global Microbiome CDMO Market: Biopharmaceutical (2021-2026) & ($ millions)
Figure 14. Microbiome CDMO in Cell Therapy
Figure 15. Global Microbiome CDMO Market: Cell Therapy (2021-2026) & ($ millions)
Figure 16. Microbiome CDMO in Others
Figure 17. Global Microbiome CDMO Market: Others (2021-2026) & ($ millions)
Figure 18. Global Microbiome CDMO Market Size Market Share by Application in 2025
Figure 19. Global Microbiome CDMO Revenue Market Share by Player in 2025
Figure 20. Global Microbiome CDMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Microbiome CDMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Microbiome CDMO Value Market Share by Country in 2025
Figure 26. United States Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Microbiome CDMO Market Size Market Share by Region in 2025
Figure 31. APAC Microbiome CDMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Microbiome CDMO Market Size Market Share by Application (2021-2026)
Figure 33. China Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Microbiome CDMO Market Size Market Share by Country in 2025
Figure 40. Europe Microbiome CDMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Microbiome CDMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Microbiome CDMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Microbiome CDMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Microbiome CDMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Microbiome CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 59. United States Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 63. China Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 67. India Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 70. France Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 71. UK Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Microbiome CDMO Market Size 2027-2032 ($ millions)
Figure 78. Global Microbiome CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Microbiome CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Microbiome CDMO Market Size 2027-2032 ($ millions)
